Navigating 6 Analyst Ratings For Moderna
Navigating 6 Analyst Ratings For Moderna
浏览 Moderna 的 6 个分析师评级
In the preceding three months, 6 analysts have released ratings for Moderna (NASDAQ:MRNA), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有6位分析师发布了Moderna（纳斯达克股票代码：MRNA）的评级，提出了从看涨到看跌的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $119.17, a high estimate of $163.00, and a low estimate of $86.00. This upward trend is apparent, with the current average reflecting a 19.56% increase from the previous average price target of $99.67.
分析师分析的12个月目标股价提供了见解，平均目标股价为119.17美元，最高估计为163.00美元，低估值为86.00美元。这种上升趋势显而易见，当前的平均价格比之前的平均目标价99.67美元上涨了19.56％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
The standing of Moderna...
通过对分...
登录免费看全文
登录/注册